![Jean-Michel Foidart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Michel Foidart
Fondateur chez
MITHRA PHARMACEUTICALS S.A.
Profil
Dr. Jean-Michel Foidart is an Executive Director at Mithra Pharmaceuticals SA. He is on the Board of Directors at EXO Biologics SA, Belma Technologies SA, Mithra Pharmaceuticals SA and Dendrogenix SA. Dr. Foidart was previously employed as a Founder by EyeD Pharma SA, a Head-Gynecology & Obstetrics by University of Liege, and a Co-Founder by Uteron Pharma SA. He also served on the board at ImCyse SA. He received his doctorate degree from the University of Liege.
Postes actifs de Jean-Michel Foidart
| Sociétés | Poste | Début |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Fondateur | 08/07/1999 |
EXO Biologics SA
 EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 29/08/2019 |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Directeur/Membre du Conseil | - |
Belma Technologies SA
 Belma Technologies SA Miscellaneous Commercial ServicesCommercial Services Engages in biotechnological research and development | Directeur/Membre du Conseil | 29/10/2015 |
Anciens postes connus de Jean-Michel Foidart
| Sociétés | Poste | Fin |
|---|---|---|
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology Manufactures and supplies ophthalmology surgical products | Fondateur | - |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Fondateur | - |
University of Liege
 University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Directeur/Membre du Conseil | - |
Formation de Jean-Michel Foidart
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Mithra Pharmaceuticals SA
 Mithra Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for woman health sector | Health Technology |
University of Liege
University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Electronic Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Belma Technologies SA
Belma Technologies SA Miscellaneous Commercial ServicesCommercial Services Engages in biotechnological research and development | Commercial Services |
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology Manufactures and supplies ophthalmology surgical products | Health Technology |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
